Does ICD indication affect quality of life and levels of distress?

PACE - Pacing and Clinical Electrophysiology

Volumn 32, Issue 2, 2009, Pages 153-156

  Pedersen, Susanne S ^a   Sears, Samuel F ^b,c   Burg, Matthew M ^d   Van Den Broek, Krista C ^a  

^a TILBURG UNIVERSITY   (Netherlands)

^b EAST CAROLINA UNIVERSITY   (United States)

^c EAST CAROLINA UNIVERSITY   (United States)

^d Department of Medicine   (United States)

Author keywords

ICD indication; Patient centered outcomes; Primary prophylaxis; Quality of life

Indexed keywords

ANXIETY; CLINICAL TRIAL; DEFIBRILLATOR; DEPRESSION; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; PROPHYLAXIS; QUALITY OF LIFE; REVIEW; TREATMENT OUTCOME;

ARRHYTHMIAS, CARDIAC; COMORBIDITY; DEFIBRILLATORS, IMPLANTABLE; HUMANS; INCIDENCE; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTORS; STRESS, PSYCHOLOGICAL;

EID: 58949087710     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2008.02196.x     Document Type: Review

References (20)

1. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chatiman B, Fromer M, Gregoratos G, et al. American College of Cardiology/American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006 114 : e385 e484.
2. Crespo EM, Kim J, Selzman KA. The use of implantable cardioverter defibrillators for the prevention of sudden cardiac death: A review of the evidence and implications. Am J Med Sci 2005 329 : 238 246.
3. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, et al. Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. New Engl J Med 2002 346 : 877 883.
4. Bardy GH, Lee KL, Mark DB, Poole Je, Packer DL, Boineau R, Domanski M, et al. Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005 352 : 225 237.
5. Seidl K, Senges J. Worldwide utilization of implantable cardioverter/defibrillators now and in the future. Card Electrophysiol Rev 2003 7 : 5 13.
6. Feder BJ. Defibrillators are lifesaver, but risks give pause. New York Times. September 12, 2008.
7. Camm AJ, Nisam S. The utilization of the implantable defibrillator- a European engima. Eur Heart J 2000 21 : 1998 2004.
8. Heidbüchel H. The cost of implantable defibrillators: How the perception of reality depends on perspective. Eur Heart J 2007 28 : 386 387.
9. Tung R, Zimetbaum P, Josephson ME. A Critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol 2008 52 : 1111 1121.
10. Hlatky MA, Mark DB. The high cost of implantable defibrillators. Eur Heart J 2007 28 : 388 391.
11. Krumholz HM, Peterson ED, Ayanian JZ, Chin MH, DeBusk RF, Goldman L, Kiefe CI, et al. National Heart, Lung, and Blood Institute working group. Report of the National Heart, Lung, and Blood Institute working group on outcomes research in cardiovascular disease. Circulation 2005 111 : 3158 3166.
12. Zimetbaum PJ. A 59-year-old man considering implantation of a cardiac defibrillator. JAMA 2007 297 : 1909 1916.
13. Bilge AK, Ozben B, Demircan S, Cinar M, Yilmaz E, Adalet K. Depression and anxiety status of patients with implantable cardioverter defibrillator and precipitating factors. Pacing Clin Electrophysiol 2006 29 : 619 626.
14. Groeneveld PW, Matta MA, Suh JJ, Yang F, Shea JA. Quality of life among implantable cardioverter-defibrillator recipients in the primary prevention therapeutic era. Pacing Clin Electrophysiol 2007 30 : 463 471.
15. Pedersen SS, Theuns DA, Muskens-Heemskerk A, Erdman RA, Jordaens L. Type-D personality but not implantable cardioverter-defibrillator indication is associated with impaired health-related quality of life 3 months post-implantation. Europace 2007 9 : 675 680.
16. Pedersen SS, Theuns DA, Erdman RA, Jordaens L. Clustering of device-related concerns and Type D personality predicts increased distress in ICD patients independent of shocks. Pacing Clin Electrophysiol 2008 31 : 20 27.
17. Sweeney MO, Wathen MS, Volosin K, Abdalla I, DeGroot PJ, Otterness MF, Stark AJ. Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: Results from the Pacing Fast VT Reduces Shock Therapies (PainFREE Rx II) trial. Circulation 2005 111 : 2898 2905.
18. Van den Broek KC, Nyklicek I, Van der Voort PH, Alings M, Denollet J. Shocks, personality, and anxiety in patients with an implantable defibrillator. Pacing Clin Electrophysiol 2008 31 : 850 857.
19. Van den Broek KC, Nyklicek I, Denollet J. Anxiety predicts poor perceived health in patients with an implantable defibrillator. Psychosomatics, In press.
20. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, Kerber RE, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines/North American Society for Pacing and Electrophysiology Committee to Update the 1998 Pacemaker Guidelines. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 2002 106 : 2145 2161.